CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $334,220 | +23.4% | 20,158 | +38.4% | 0.02% | +11.1% |
| Q4 2022 | $270,835 | -10.3% | 14,561 | -38.0% | 0.02% | -10.0% |
| Q3 2022 | $302,000 | -60.0% | 23,504 | -83.5% | 0.02% | -52.4% |
| Q3 2021 | $755,000 | -4.3% | 142,529 | +3.9% | 0.04% | 0.0% |
| Q2 2021 | $789,000 | +39.9% | 137,216 | +12.1% | 0.04% | +31.2% |
| Q1 2021 | $564,000 | +96.5% | 122,419 | +42.6% | 0.03% | +52.4% |
| Q4 2020 | $287,000 | +63.1% | 85,874 | +45.0% | 0.02% | +250.0% |
| Q3 2020 | $176,000 | +175.0% | 59,234 | +375.6% | 0.01% | +500.0% |
| Q1 2019 | $64,000 | – | 12,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |